MCDONNELL RAYMOND KARL

CEO McDonnell sells 38,840 STRA shares ($2.9M) at $75.12–$75.55 on 2026-02-24; holds 158,978 shares post-sale.

MCDONNELL RAYMOND KARL (CHIEF EXECUTIVE OFFICER) sold 38,840 shares across 2 separate transactions totaling $2,926,599.64 at blended average price $75.35, reducing holdings by 19.6% to 158,978 shares. His prior trades at STRA show mixed timing outcomes: 2 of 3 prior sells were well-timed at the 90-day mark, with 2025 sales declining 10.5–11.0% in the subsequent 90 days, though a 2024 sale gained 19.6%. Current price of $78.41 sits 22.9% below the 52-week high of $101.72 and has fallen 6.6% over the trailing 30 days. The company shows solid fundamentals with $319.9M quarterly revenue, $26.6M net income, and 7.7% annual growth, suggesting the sale reflects portfolio reallocation rather than fundamental deterioration at the company level.

CEO McDonnell sells 31,855 shares at $97.83 avg for $3.1M; stock now down 35.1% from 52-week high to $79.80

McDonnell executed 2 separate sales totaling 31,855 shares for $3,116,343.92 on 2025-02-25, reducing his stake by 15.5% to 173,465 shares post-transaction. The transaction occurred at a blended average price of $97.83, but the stock has since declined to $79.80 (current price), representing a -35.1% drawdown from its 52-week high of $123.00. In his prior trade at STRA on 2024-02-27, the stock appreciated 8.5% over 30 days and 19.6% over 90 days after the sale—a poorly timed sale in hindsight. The current fundamental backdrop remains solid: FY revenue growth of +7.7%, net income of $27.7M on quarterly revenue of $306.0M, and a P/E of 11.55. Investors should note the timing context: the CEO sold into a price that now appears elevated relative to current levels, and the recent 30-day and 90-day declines (-18.3% and -19.2% respectively) contrast with prior post-sale performance, though causality cannot be inferred from a single filing.